索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]李昕,刘世栋,朱鹏冲,等.经导管主动脉瓣置入术的研究进展[J].国际心血管病杂志,2018,01:8-11.
点击复制

经导管主动脉瓣置入术的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2018年01期
页码:
8-11
栏目:
综述
出版日期:
2018-01-25

文章信息/Info

Title:
-
作者:
李昕; 刘世栋; 朱鹏冲; 宋兵
730099 兰州大学第一临床医学院(李昕,刘世栋,朱鹏冲); 兰州大学第一医院心外科(宋兵)
Author(s):
-
关键词:
主动脉瓣狭窄;  经皮主动脉瓣置换术;  经导管主动脉瓣置换术;  主动脉瓣置换
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-534X.2018.01.003
文献标识码:
-
摘要:
2002年,经导管主动脉瓣置入术(TAVI)首次在人体成功开展,之后TAVI获得了较快发展。该文介绍TAVI在入路途径、器械发展、适应证、并发症和心脏团队模式等方面的研究进展。
Abstract:
-

参考文献/References

[1] Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description[J]. Circulation, 2002, 106(24):3006-3008.
[2] Pascual I, Carro A, Avanzas PA, et al. Vascular approaches for transcatheter aortic valve implantation[J]. J Thorac Dis, 2017, 9(6):S478-S487.
[3] Ando T, Takagi H, Transfemoral GL. Transfemoral, transapical and transcatheter aortic valve implantation and surgical aortic valve replacement: a meta-analysis of direct and adjusted indirect comparisons of early and mid-term deaths[J]. Interact Cardiovasc Thorac Surg, 2017, 25(3):484-492.
[4] Guinot PG, Depoix JP, Etchegoyen LA, et al. Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications[J]. J Cardiothorac Vasc Anesth, 2010, 24(5):752-761.
[5] Walther T, Mollmann H, van Linden A, et al. Transcatheter aortic valve implantation transapical: step by step[J]. Semin Thorac Cardiovasc Surg, 2011, 23(1):55-61.
[6] Panchal HB, Ladia V, Amin P, et al. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapicaltranscatheter aortic valve implantation using edwards valve for severe aortic stenosis[J]. Am J Cardiol, 2014, 114(12):1882-1890.
[7] Caceres M, Braud R, Roselli EE. The axillary/subclavian artery access route for transcatheter aortic valve replacement: a systematic review of the literature[J]. Ann Thorac Surg,2012, 93(3):1013-1018.
[8] Lardizabal JA, O’Neill BP, Desai HV, et al.The transaortic approach for transcatheter aortic valve replacement: initial clinical experience in the United States[J]. J Am Coll Cardiol, 2013, 61(23):2341-2345.
[9] Azmoun A, Amabile N, Ramadan R, et al. Transcatheter aortic valve implantation through carotid artery access under local anaesthesia[J]. Eur J Cardiothorac Surg, 2014, 46(4):693-698.
[10] Greenbaum AB, O’Neill WW, Paone G, et al. Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience[J]. J Am Coll Cardiol, 2014, 63(25 Pt A):2795-2804.
[11] Abdel-Wahab M, Neumann FJ, Mehilli JA, et al. 1-year outcomes after transcatheter aortic valve replacement with balloon-expandable versus self-expandable valves results from the CHOICE randomized clinical trial[J]. J Am Coll Cardiol, 2015, 66(7):791-800.
[12] Giannini C, De Carlo M, Tamburino CA, et al. Transcathether aortic valve implantation with the new repositionable self-expandable Evolut R versus CoreValve system: a case-matched comparison[J]. Int J Cardiol, 2017, 243:126-131.
[13] Maeno Y, Yoon SH, Abramowitz Y, et al. Effect of ascending aortic dimension on acute procedural success following self-expanding transcatheter aortic valve replacement: a multicenter retrospective analysis[J]. Int J Cardiol, 2017, 244:100-105.
[14] Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis[J]. N Engl J Med, 2014, 370(19):1790-1798.
[15] Deeb GM, Reardon MJ, Chetcuti S, et al. 3-year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement[J]. J Am Coll Cardiol, 2016, 67(22):2565-2574.
[16] Jabbour RJ, Pagnesi M, Kawamoto HA, et al. Transcatheter aortic valve implantation in intermediate- and low-risk populations: an inevitable progression?[J]. Int J Cardiol, 2016, 210:35-37.
[17] Castrodeza J, Amat-Santos IJ, Blanco MA, et al. Propensity score matched comparison of transcatheter aortic valve implantation versus conventional surgery in intermediate and low risk aortic stenosis patients:a hint of real-world[J]. Cardiol J, 2016, 23(5): 541-551.
[18] ACC News Story. GARY: TAVR vs SAVR in intermediate surgical risk severe AS[EB/OL].
[2016-11-14] http://www.acc.org/latest-in-cardiology/articles/2016/11/10/15/56/mon-1145amet-germany-patients-at-intermediate-surgical-risk-aha-2016.
[19] Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease[J]. J Am Coll Cardiol, 2017, 70(2):252-289.
[20] Iturra SA, Suri RM, Greason KL, et al. Outcomes of surgical aortic valve replacement in moderate risk patients: implications for determination of equipoise in the transcatheter era[J]. J Thorac Cardiovasc Surg, 2014, 147(1):127-132.
[21] Patel HJ, Herbert MA, Drake DH, et al. Aortic valve replacement: using a statewide cardiac surgical database identifies a procedural volume hinge point[J]. Ann Thorac Surg, 2013, 96(5):1560-1566.
[22] Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery[J]. N Engl J Med, 2011, 364(22):2128-2137.
[23] Bestehorn K, Eggebrecht H, Fleck E, et al. Volume-outcome relationship with transfemoraltranscatheter aortic valve implantation(TAVI): insights from the compulsory German Quality Assurance Registry on Aortic Valve Replacement(AQUA)[J]. EuroIntervention, 2017, 13(8): 914-920.
[24] Baumbach H, Ahad S, Rustenbach C, et al. Conventional versus transapical aortic valve replacement: is it time for shift in indications?[J]. Thorac Cardiovasc Surg, 2017, 65(3):212-217.
[25] Indraratna P, Tian DH, Yan TD, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement: a meta-analysis of randomized controlled trials[J]. Int J Cardiol, 2016, 224:382-387.
[26] Chiam PT, Ewe SH, Soon JL, et al. Percutaneous transcatheter aortic valve implantation for degenerated surgical bioprostheses: the first case series in Asia with one-year follow-up[J]. Singapore Med J, 2016, 57(7):401-405.
[27] Mylotte D, Andalib A, Thériault-Lauzier P, et al. Transcatheter heart valve failure: a systematic review[J]. Eur Heart J, 2015, 36(21):1306-1327.
[28] Siemieniuk RA, Agoritsas T, Manja V, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis[J]. Br Med J, 2016, 354:i5130.
[29] Ando T, Takagi HA. Percutaneous closure of paravalvular regurgitation after transcatheter aortic valve implantation:a systematic review[J].Clin Cardiol, 2016, 39(10):608-614.
[30] Ussia GP, Barbanti M, Sarkar K, et al. Transcatheter aortic bioprosthesis dislocation: technical aspects and midterm follow-up[J]. EuroIntervention, 2012, 7(11):1285-1292.
[31] Mitrosz M, Kazimierczyk R, Sobkowicz BA, et al. The causes of thrombocytopenia after transcatheter aortic valve implantation[J]. Thromb Res, 2017, 156:39-44.
[32] Lareyre F, Raffort J, Dommerc C,et al. Surgical management of percutaneous transfemoral access to minimize vascular complications related to transcatheter aortic valve’ implantation[J]. Angiology, 2018, 69(2):143-150.
[33] Doerner J, Kupczyk PA, Wilsing M, et al. Cerebral white matter lesion burden is associated with the degree of aortic valve calcification and predicts peri-procedural cerebrovascular events in patients undergoing transcatheter aortic valve implantation(TAVI)[J]. Catheter Cardiovasc Interv, 2017, May 26.[Epub ahead of print].
[34] Pavasini R, Ruggerini S, Grapsa J, et al. Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: a systematic review and meta-analysis[J]. Eur Heart J Cardiovasc Imaging, 2017, Jun 5.[Epub ahead of print].
[35] Varadarajan P, Kapoor N, Bansal RC, et al. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis[J]. Ann Thorac Surg, 2006, 82(6):2111-2115.
[36] Booth K, Beattie R, Mcbride M, et al. High risk aortic valve replacement—the challenges of multiple treatment strategies with an evolving technology[J].Ulster Med J, 2016, 85(1):18-22.

备注/Memo

备注/Memo:
通信作者:宋兵,Email:abcsong@sina.com
更新日期/Last Update: 2018-04-01